Stockreport

Mural Oncology to Present at the TD Cowen 45th Annual Health Care Conference

Mural Oncology plc - Ordinary Shares  (MURA) 
PDF WALTHAM, Mass and DUBLIN, Feb. 18, 2025 (GLOBE NEWSWIRE) -- Mural Oncology plc (Nasdaq: MURA), a clinical-stage immuno-oncology company developing novel, investigation [Read more]